Such an ADAM protease is ADAM8, which has been proven to exhibit tumor-supportive activities when expressed in cancer cells, thereby promoting cancer progression, invasion, and enhancing immune cell enrolment (Schlomann et al., 2015; Conrad et al., 2019). Here, ADAM8 is linked to neoplasm.